Somatrogon

  • Part D specialty tier in 73% of formularies (2026Q3)
  • Biologic
  • Ngenla

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Somatrogon: storage and handling

Refrigerate
Yes, as the label states
Label statement
Before first use: Store refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
Freezing
Do not freeze
Label statement
Do not freeze or shake.
Room temperature
No allowance stated
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Before first use: Store refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

The label does not state a room-temperature allowance for this product.

Entered: 1 day at up to 77°F (25°C).

Before first use: Store refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
Do not freeze or shake.

Contact the manufacturer at 1-800-645-1280 (the number printed on the label) about this product.

Where the label prints this number
Call your healthcare provider if you or your caregiver have any questions about the right way to inject NGENLA, or call the helpline on 1-800-645-1280.
All storage statements on the label (19)
  • Before first use: Store refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
  • After first use: Store the pen refrigerated at 36°F to 46°F (2°C to 8°C) between each use, for up to 28 days.
  • Do not freeze or shake.
  • Do not expose to heat.
  • Do not use if it has been frozen.
  • Store away from direct sunlight.
  • Always remove and safely discard the needle after each injection and store the NGENLA prefilled pen without an injection needle attached.
  • How should I store my pen? ).
  • Storage and disposal: How should I store my pen? .
  • Do not freeze your pen or expose it to heat. .
  • Do not use your pen if it has been frozen or stored in direct sunlight. .
  • Do not use after the expiration date printed on the label has passed or if it has been more than 28 days after first use. .
  • How should I store NGENLA? .
  • Do not use after the expiration date printed on the label has passed or if it has been more than 28 days after first use.
  • Store in the original carton. .
  • Store the new, unused NGENLA pen in the refrigerator between 36°F to 46°F (2°C to 8°C). .
  • Unused prefilled pens may be used until the expiration date printed on the pen label, if kept in the refrigerator.
  • Store remaining NGENLA in the refrigerator between 36°F to 46°F (2°C to 8°C) and use within 28 days. .
  • Do not store the remaining NGENLA pen with a needle attached. .

FDA label version 14, effective August 14, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

0%of plans list it
100%of those: prior authorization
0%step therapy
0%quantity limit
76%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.